Scientists successfully sequence the RNA from woolly mammoths found in Siberia that lived up between 10,000 thousand and ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

Exsilio Therapeutics launched on Wednesday with an $82 million series A fundraising round co-led by Novartis Venture Fund and Delos Capital. The company’s interim CEO, Tal Zaks, says that while ...

Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines ...

MUNICH, Germany--(BUSINESS WIRE)--Ethris GmbH, a leading biotechnology company pioneering transformative messenger RNA (mRNA) therapeutics, announced today that it has raised $26.3 Million (€23.3 ...

< Photo 1. (From left) Professor Won Do Heo and Jihwan Yu, a Ph.D. Candidate of the Department of Biological Sciences > CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing ...

SAN FRANCISCO (AP) _ The biotechnology field is littered with the debris of would-be miracle cures. These days, the buzz is building around a technology called ``RNA interference,'' whose legions of ...

DURING THE covid-19 pandemic new vaccines were rolled out with unprecedented speed. The fastest to arrive were jabs built from molecules of messenger RNA (mRNA) designed to teach the body how to fight ...